Specialists

WHO guideline. USE OF MULTIPLE MICRONUTRIENT POWDERS FOR POINT-OF-USE FORTIFICATION OF FOODS CONSUMED by infants and young children aged 6–23 months and children aged 2–12 years

WHO guideline. USE OF MULTIPLE MICRONUTRIENT POWDERS FOR POINT-OF-USE FORTIFICATION OF FOODS CONSUMED by infants and young children aged 6–23 months and children aged 2–12 years

Efficacy and safety of liposomal form of iron in the treatment of iron deficiency anemia in tender-age infants

Efficacy and safety of liposomal form of iron in the treatment of iron deficiency anemia in tender-age infants

Impact of anemia in the course of cardiovascular disease

Impact of anemia in the course of cardiovascular disease

Efficacy of oral iron administration compared with intravenous iron administration in the treatment of iron deficiency anemia in patients with CKD

Efficacy of oral iron administration compared with intravenous iron administration in the treatment of iron deficiency anemia in patients with CKD

Iron deficiency and anemia in patients with chronic heart failure

Iron deficiency and anemia in patients with chronic heart failure

DAILY IRON SUPPLEMENTATION in adult women and adolescent girls. WHO

DAILY IRON SUPPLEMENTATION in adult women and adolescent girls. WHO

Efficacy and safety of sucrosomal iron in pregnant women

Efficacy and safety of sucrosomal iron in pregnant women

Correction of iron deficiency anemia in patients with gynecological diseases by application of liposomal iron

Correction of iron deficiency anemia in patients with gynecological diseases by application of liposomal iron

Complex conservative treatment of patients with moderate IDA in the course of menorrhagia treatment

Complex conservative treatment of patients with moderate IDA in the course of menorrhagia treatment

Anemic syndrome in patients with tumors of the female reproductive system

Anemic syndrome in patients with tumors of the female reproductive system

Oral sucrosomal iron supplements in patients after undergone bariatric surgery

Oral sucrosomal iron supplements in patients after undergone bariatric surgery

Comparative efficacy of a new sucrosomal form of iron for oral administration and intravenous ferrotherapy in the treatment of anemia in patients with inflammatory bowel disease

Comparative efficacy of a new sucrosomal form of iron for oral administration and intravenous ferrotherapy in the treatment of anemia in patients with inflammatory bowel disease

1
2

© 2026

International Pharmaceutical Company-Distributor Office in Ukraine: Kyiv, st. Oleksy Tykhoho, 16/15 ZydexUA. info@zydex.com.ua

Designed by